Previous clinical studies have shown that FGF23 and α-klotho have highly valuable predictive effects on cardiovascular disease (CVD) in patients with T2DM [40–45], but atherosclerosis, the initial cause of cardiovascular events, has received relatively little attention [46]. This evidence concerns the gene FGF23 and cardiovascular disorder.